Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Claude Cormier who wrote (3269)	2/3/2000 8:59:00 PM
From: Mark Bartlett	Respond to of 14101

Claude, Re: Sales of Pennsaid. There is a poster here (Wolf, the computer whiz) who has prepared a spreadsheet with various scenarios -- if you want I am sure he would send you a copy. Let me know and I'll ask him to send you the mumbers. If he sees this post, he'll likely send them to you .... Wolf are you out there? I would not worry too much about the present market cap -- the market will be looking at the potential future revenue stream, which is very high. DMX has to only capture a very small % of that to be very successful. Then there is the potential use of the carrier molecule for other meds. As far as the FDA approval goes, we have been told that the last part of that process is a plant inspection of the production facility. That should be happening in the next couple of months .... at least that is our hope. MB